GlassScriptPhysician profile
Paul D Dimusto
NPI 1205954096
$3,054.97
in general payments reported to CMS, 2019-2025
7 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $193 · 2022: $213 · 2023: $2,059 · 2024: $234 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,679 · Food and Beverage: $970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,679.00 |
| Food and Beverage | $970.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,915.35 | 2023 | Product In Development, Gore Tag Thoracic Endoprosthesis |
| Penumbra, INC. | $468.64 | 2023-2025 | Indigo System, Penumbra System |
| Silk Road Medical, INC. | $383.88 | 2021-2022 | |
| Shockwave Medical, INC | $99.86 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bolton Medical INC | $82.80 | 2025 | Treo Abdominal Stent-Graft System |
| Shape Memory Medical INC. | $82.62 | 2025 | Impede Embolization Plug |
| Lemaitre Vascular, INC. | $21.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Dimusto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.